Absci Corporation (ABSI) vs Avalyn Pharma Inc. (AVLN)

Absci Corporation and Avalyn Pharma Inc. are both Biotechnology companies. Absci Corporation and Avalyn Pharma Inc. are of similar size ($1.3B and $1.2B). Avalyn Pharma Inc. has the higher net margin (0.00% vs −8,451.3%) and the higher return on invested capital (−127.6% vs −182.0%). Across the 11 metrics below, Avalyn Pharma Inc. leads on 9 and Absci Corporation on 2.

Valuation

Metric ABSI AVLN Biotechnology median
P/E n/m n/m 10.01
P/S 875.75 n/m 9.02
P/B 5.96 3.34 2.13
Price to free cash flow n/m n/m 24.99
EV/EBITDA n/m n/m 0.64
EV/Sales 759.00 n/m 9.01
Earnings yield (10.47%) (157.17%) (34.01%)
Free cash flow yield (8.62%) (8.11%) (24.62%)

Profitability

Metric ABSI AVLN Biotechnology median
Gross margin 100.00% — 70.18%
Operating margin (8,812.31%) 0.00% 0.00%
Net margin (8,451.31%) 0.00% 0.00%
Free cash flow margin (7,550.91%) 0.00% 0.00%
Return on equity (58.59%) 0.00% (50.72%)
Return on assets (51.87%) 0.00% (45.56%)
Return on invested capital (181.96%) (127.60%) 0.00%

Growth

Metric ABSI AVLN Biotechnology median
Revenue growth (TTM) (47.18%) — 7.42%
EPS growth (last fiscal year) 10.64% — 29.36%
Revenue growth, 5-year CAGR (10.14%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ABSI AVLN Biotechnology median
Debt to equity 0.00 0.04 0.00
Current ratio 9.64 25.76 4.72
Net debt to EBITDA 1.32 — 1.01

Dividend

Metric ABSI AVLN Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ABSI AVLN Biotechnology median
Market cap 1.31b 1.24b 157.22m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack